50700-72-6 Vecuronium bromide AKSci J55107
 
 
Loading Please Wait...
  J55107    
Vecuronium bromide, 95%
 
1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-Bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methyl-piperidinium bromide
IDENTITY
CAS Number:50700-72-6
MDL Number:MFCD00867762
MF:C34H57N2O4.Br
MW:637.73
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:95%
Physical Form (at 20°C):Solid
Melting Point:227-234°C
Optical Rotation:+31.0 to +34.0° (c=1, 0.05mol/L HCl)
Long-Term Storage:Store long-term at -20°C
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

BIOLOGICAL INFO
Solubility:Soluble in water
Application(s):Non-depolarizing neuromuscular blocking agent

REVIEW
 Vecuronium is a bisquaternary nitrogen compound that acts by competitively binding to nicotinic cholinergic receptors. The binding of vecuronium decreases the opportunity for acetylcholine to bind to the nicotinic receptor at the postjunctional membrane of the myoneural junction. As a result, depolarization is prevented, calcium ions are not released and muscle contraction does not occur.

REFERENCES
[1]Yiu, K. C. H.; Chromatographia 2004, V59(Suppl. 1), PS45-S50
[2] Thieme, Detlef; Analytica Chimica Acta 2003, V492(1-2), P171-186

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Warning

Hazard Statements
H302

Precautionary Statements
P264; P270; P301+P312; P330; P501

RELATED PRODUCTS
H858Vecuronium bromide
H896Rocuronium bromide

Current as of December 3, 2023


Download SDS Request COA

⚠️
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.


CATEGORIES
 APIs and Bioactives > AChR Antagonists


PubChem